INTRODUCTION

Diphtheria is now rare in the United States, but people still get the disease. And there have been large outbreaks in countries where vaccination rates have gone down.

Diphtheria can cause serious complications, like paralysis (not being able to move), pneumonia (lung infection), and lung failure. It can also be deadly, especially for certain age groups — 1 in 10 people will die from diphtheria even with treatment.

Getting vaccinated is the best way to prevent diphtheria. And when enough people get vaccinated against diphtheria, the entire community is less likely to get it. So, when you and your family get vaccinated, you help keep yourselves and your community healthy.

WHO NEED VACCINE?

• 2 months
• 4 months
• 6 months
• 15 through 18 months
• 4 through 6 years
• Preteens and teens ages 7 through 18
• Adults age 19 and older
• Pregnant women

SIDE EFFECTS

Side effects are usually mild and go away in a few days. They may include:

• Pain, swelling, or redness where the shot was given
• Low fever and chills
• Headache and body aches
• Feeling tired
• Upset stomach, throwing up, and diarrhea (watery poop)
• Not feeling hungry
• Fussing (in children)

Our Journal is planning to release a year end special issue has announced almost 50% discount on article publication charges to celebrate its journey for publishing articles within the short time.

 A standard editorial manager system is utilized for manuscript submission, review, editorial processing and tracking which can be securely accessed by the authors, reviewers and editors for monitoring and tracking the article processing.

Manuscripts can be forwarded to the Editorial Office at autoimmunedis@eclinicalsci.com

How we work:

• After submission, an acknowledgement with manuscript number is sent to the corresponding author within 7 working days.
• A 21 day window time frame is allotted for peer-review process wherein multiple experts are contacted.
• Author proof is generated within 7 working days after the acceptance decision.

Benefits on Publication:

Open Access: Permanent free access to your article upon publication ensures extensive global reach and readership.

Easy Article Sharing: Our open access enables you to share your article directly with colleagues through email and on social media via a single link, permitting third party reuse with appropriate citation in addition to the retention of content copyright by the author.

Global Marketing: Through promotion in a targeted global email announcement or press release, your article will be seen by thousands of the top-most thought-leaders in your field.

Color Art: In a world of black & white journal articles, high-quality full-color images make your article stand out from the crowd and tell a complete story, increasing readers and citations.

Social Media Exposure: Extended reach for your article through links on Twitter accounts provides maximum visibility worldwide.

Reprints: Distribute your work to colleagues and at conferences as we provide hard copy color reprints of your article on order.

Media Contact:
John Kimberly
Editorial Manager
Journal of Vaccines & Vaccination
Email: jvv@scholarlypub.com